Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by BIGHAM MICHAEL

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardFeb 02, 2018Option Exercise$4.3023,25599,9971,358,032Sep 21, 2023, 01:18 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardAug 09, 2023Sale$2.2031,25068,7501,334,702Aug 10, 2023, 08:35 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardDec 21, 2022Sale$1.9915,75031,3431,209,702Dec 22, 2022, 04:26 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardDec 12, 2022Sale$1.9819,48438,5781,212,343Dec 14, 2022, 08:00 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardDec 13, 2022Sale$1.9631,89162,5061,180,452Dec 14, 2022, 08:00 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardOct 28, 2022Sale$3.476,00020,8201,231,827Nov 01, 2022, 07:51 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardAug 09, 2022Sale$2.6628,63776,1741,207,827Aug 10, 2022, 09:00 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardDec 15, 2021Sale$4.2717,81976,087890,782Dec 15, 2021, 09:02 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardDec 13, 2021Sale$4.425,05922,361917,223Dec 15, 2021, 09:02 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardDec 14, 2021Sale$4.378,62237,678908,601Dec 15, 2021, 09:02 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardAug 17, 2021Sale$5.1232,030163,994922,282Aug 18, 2021, 07:16 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardDec 11, 2020Sale$6.9518,337127,442572,580Dec 15, 2020, 07:47 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardDec 14, 2020Sale$6.7126,063174,883546,517Dec 15, 2020, 07:47 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardNov 13, 2020Sale$5.9326,250155,662590,917Nov 16, 2020, 06:30 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELExec. Chairman of the BoardMay 12, 2020Sale$4.6812,25057,330542,167May 14, 2020, 06:23 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELChairman and CEODec 12, 2018Sale$6.768,40056,784256,467Dec 14, 2018, 05:45 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELChairman and CEOOct 15, 2018Sale$8.966,30056,448264,867Oct 16, 2018, 08:02 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELChairman and CEOOct 03, 2018Sale$9.8216,313160,194257,167Oct 04, 2018, 09:06 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELChairman and CEOJul 02, 2018Sale$9.9722,500224,325177,230Jul 05, 2018, 06:21 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELChairman and CEOApr 09, 2018Sale$12.708,700110,490199,730Apr 10, 2018, 07:38 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELChairman and CEOFeb 05, 2018Sale$14.224,00056,880123,680Feb 07, 2018, 06:21 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELChairman and CEOJul 19, 2017Option Exercise$4.3023,25599,997127,680Jul 21, 2017, 04:34 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELChairman and CEOJul 05, 2017Sale$23.585,075119,662104,425Jul 06, 2017, 04:36 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELChairman and CEOFeb 06, 2017Sale$15.095,00075,46999,970Feb 08, 2017, 06:30 PM
PRTKParatek Pharmaceuticals, Inc.BIGHAM MICHAELChairman and CEOJun 23, 2016Buy$13.4520,000269,014100,000Jun 27, 2016, 04:26 PM
SUPNSUPERNUS PHARMACEUTICALS INCBIGHAM MICHAELDirectorMar 20, 2013Buy$5.175,00025,8605,000Mar 26, 2013, 04:33 PM
SUPNSUPERNUS PHARMACEUTICALS INCBIGHAM MICHAELDirectorMar 20, 2013Buy$5.205,00025,9755,000Mar 26, 2013, 04:33 PM
SUPNSUPERNUS PHARMACEUTICALS INCBIGHAM MICHAELDirectorMar 20, 2013Buy$5.2610,00052,64010,000Mar 26, 2013, 04:33 PM
SUPNSUPERNUS PHARMACEUTICALS INCBIGHAM MICHAELDirectorMar 22, 2013Buy$5.6515,00084,79525,000Mar 26, 2013, 04:33 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe